Liste complète par ordre alphabétique
- Liste alphabétique
- Abatacept (ORENCIA®)
- Abciximab (REOPRO®)
- Adalimumab
- Aflibercept (ZALTRAP®, EYLEA®)
- Alemtuzumab (LEMTRADA®)
- Alirocumab (PRALUENT®)
- Anakinra (KINERET®)
- Atezolizumab (TECENTRIQ®)
- Avelumab (BAVENCIO®)
- Basiliximab (SIMULECT®)
- Belatacept (NULOJIX®)
- Belimumab (BENLYSTA®)
- Benralizumab (FASENRA®)
- Besilesomab (SCINTIMUN®)
- Bevacizumab
- Beztoloxumab (ZINPLAVA®)
- Blinatumomab (BLINCYTO)
- Brentuximab vedotin (ADCETRIS®)
- Brodalumab (KYNTHEUM®)
- Brolucizumab (BEOVU®)
- Burosumab (CRYSVITA®)
- Canakinumab (ILARIS®)
- caplacizumab (CABLIVI®)
- Catumaxomab (REMOVAB®)
- Cemiplimab (LIBTAYO®)
- Certolizumab pegol (CIMZIA®)
- Cetuximab (ERBITUX®)
- Daclizumab (ZINBRYTA®)
- Daratumumab (Darzalex®)
- Denosumab (PROLIA®, XGEVA®)
- Dinutuximab beta (QARZIBA®)
- Dupilumab (DUPIXENT®)
- Durvalumab (IMFINZI®)
- Eculizumab (SOLIRIS®)
- Elotuzumab (Empliciti®)
- Emicizumab (HEMLIBRA®)
- Erenumab (AIMOVIG®)
- Etanercept
- Evolocumab (Repatha®)
- Fremanezumab (AJOVY®)
- Galcanezumab (EMGALITY®)
- Golimumab (SIMPONI®)
- Guselkumab (TREMFYA®)
- Ibalizumab (TROGARZO®)
- Ibritumomab (ZEVALIN®)
- Idarucizumab (PRAXBIND®)
- Infliximab
- inotuzumab ozogamicin (BESPONSA®)
- Ipilimumab (YERVOY®)
- Isatuximab (SARCLISA®)
- Ixekizumab (TALTZ®)
- Lanadélumab (TAKHZYRO®)
- Mepolizumab (NUCALA®)
- Mogamulizumab (POTELIGEO®)
- Natalizumab (TYSABRI®)
- Necitumumab (PORTRAZZA®)
- Nivolumab (OPDIVO®)
- Obinutuzumab (GAZYVARO®)
- Ocrelizumab (OCREVUS®)
- Ofatumumab (KESIMPTA®)
- Olaratumab (LARTRUVO®)
- Omalizumab (XOLAIR®)
- Palivizumab (SYNAGIS®)
- Panitumumab (VECTIBIX®)
- Pembrolizumab (KEYTRUDA®)
- Pertuzumab (PERJETA®)
- Pertuzumab-trastuzumab (PHESGO®)
- Polatuzumab vedotin (POLIVY®)
- Ramucirumab (CYRAMZA®)
- Ranibizumab (LUCENTIS®)
- ravulizumab (Ultomiris®)
- Reslizumab (CINQAERO®)
- Risankizumab (SKYRIZI®)
- Rituximab
- Sarilumab (KEVZARA®)
- Secukinumab (COSENTYX®)
- Siltuximab (SYLVANT®)
- Tildrakizumab (ILUMETRI®)
- Tocilizumab (ROACTEMRA®)
- Trastuzumab
- Ustekinumab (STELARA®)
- Vedolizumab (ENTYVIO®)